Alumis Inc (ALMS)’s stock performance: a year in review

While Alumis Inc has overperformed by 2.27%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ALMS fell by -54.20%, with highs and lows ranging from $13.50 to $2.76, whereas the simple moving average fell by -47.48% in the last 200 days.

On June 10, 2025, Guggenheim started tracking Alumis Inc (NASDAQ: ALMS) recommending Buy. A report published by Oppenheimer on January 30, 2025, Initiated its previous ‘Outperform’ rating for ALMS. Robert W. Baird also rated ALMS shares as ‘Outperform’, setting a target price of $25 on the company’s shares in an initiating report dated October 31, 2024. H.C. Wainwright Initiated an Buy rating on October 17, 2024, and assigned a price target of $30. Morgan Stanley initiated its ‘Overweight’ rating for ALMS, as published in its report on July 23, 2024. Leerink Partners’s report from July 23, 2024 suggests a price prediction of $29 for ALMS shares, giving the stock a ‘Outperform’ rating. Guggenheim also rated the stock as ‘Buy’.

Analysis of Alumis Inc (ALMS)

There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Alumis Inc’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -247.05% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.73, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

As an indicator of volatility for any stock, average volume can also be very valuable, and ALMS is recording an average volume of 812.25K. On a monthly basis, the volatility of the stock is set at 7.83%, whereas on a weekly basis, it is put at 5.48%, with a gain of 8.76% over the past seven days. Furthermore, long-term investors anticipate a median target price of $19.40, showing growth from the present price of $3.6, which can serve as yet another indication of whether ALMS is worth investing in or should be passed over.

How Do You Analyze Alumis Inc Shares?

Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 34.47%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 23.34% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

Hot this week

Right Now, Here’s How You Can Trade CRISPR Therapeutics AG (CRSP) Aggressively

Currently, CRISPR Therapeutics AG's (CRSP) stock is trading at...

The VNET Group Inc ADR (VNET) Stock Is Headed for a Correction

In the current trading session, VNET Group Inc ADR's...

Choosing between riding the trend or protecting profits: Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)'s stock is trading at $10.95...

Our Attention Has Been Attracted to Glimpse Group Inc (NASDAQ:VRAR)

Glimpse Group Inc (VRAR)'s stock has witnessed a price...

Observations on the Teladoc Health Inc (NYSE:TDOC) Growth Curve

Currently, Teladoc Health Inc's (TDOC) stock is trading at...

Topics

Right Now, Here’s How You Can Trade CRISPR Therapeutics AG (CRSP) Aggressively

Currently, CRISPR Therapeutics AG's (CRSP) stock is trading at...

The VNET Group Inc ADR (VNET) Stock Is Headed for a Correction

In the current trading session, VNET Group Inc ADR's...

Choosing between riding the trend or protecting profits: Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)'s stock is trading at $10.95...

Our Attention Has Been Attracted to Glimpse Group Inc (NASDAQ:VRAR)

Glimpse Group Inc (VRAR)'s stock has witnessed a price...

Observations on the Teladoc Health Inc (NYSE:TDOC) Growth Curve

Currently, Teladoc Health Inc's (TDOC) stock is trading at...

What Are the Chances of Atyr Pharma Inc (ATYR) Stagnating? Here is the INSIGHT

Atyr Pharma Inc (ATYR)'s stock is trading at $5.59...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.